Foxp3-dependent programme of regulatory T-cell differentiation

Nature

Volumn 445, Issue 7129, 2007, Pages 771-775

  Gavin, Marc A ^a,d   Rasmussen, Jeffrey P ^a   Fontenot, Jason D ^a   Vasta, Valeria ^b   Manganiello, Vincent C ^c   Beavo, Joseph A ^b   Rudensky, Alexander Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 3B; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

DIFFERENTIATION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL SURFACE; CLONAL ANERGY; CONTROLLED STUDY; ENZYME REPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

MUS;

EID: 33847153417     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05543     Document Type: Article

References (23)

1. Fontenot, J. D. & Rudensky, A. Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nature Immunol. 6, 331-337 (2005).
2. van Santen, H. M., Benoist, C. & Mathis, D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200, 1221-1230 (2004).
3. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
4. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
5. Wildin, R. S. & Freitas, A. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun. 25 (suppl.), 56-62 (2005).
6. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
7. Hsieh, C. S., Zheng, Y., Liang, Y., Fontenot, J. D. & Rudensky, A. Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nature Immunol. 7, 401-410 (2006).
8. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341 (2005).
9. Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
10. Ivanov, I. I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17(1) T helper cells. Cell 126, 1121-1133 (2006).
11. Williams, L. M. & Rudensky, A. Y. Maintenance of the Foxp3 dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunol. (in the press).
12. Chan, C. W. et al. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J. Immunol. 170, 4036-4044 (2003).
13. Stumhofer, J. S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunol. 7, 937-945 (2006).
14. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nature Immunol. 7, 929-936 (2006).
15. Yegutkin, G. G., Henttinen, T., Samburski, S. S., Spychala, J. & Jalkanen, S. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. Biochem. J. 367, 121-128 (2002).
16. Yegutkin, G. G., Samburski, S. S., Jalkanen, S. & Novak, I. ATP-consuming and ATP-generating enzymes secreted by pancreas. J. Biol. Chem. 281, 29441-29447 (2006).
17. Ohta, A. & Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920 (2001).
18. Erdmann, A. A. et al. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105, 4707-4714 (2005).
19. Sheppard, F. R. et al. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukoc. Biol. 78, 1025-1042 (2005).
20. Torgersen, K. M., Vang, T., Abrahamsen, H., Yaqub, S. & Tasken, K. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal. 14, 1-9 (2002).
21. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature doi:10.1038/nature05563 (in the press).
22. Zhang, W. & Colman, R. W. Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding. Blood 95, 3380-3386 (2000).
23. Choi, Y. H. et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J. Clin. Invest. 116, 3240-3251 (2006).